Tag: PrEP
Tom Naves from Body Positive highlights the importance of sexual health, especially during Pride season in Aotearoa, New Zealand.
In February, we celebrate our resilience and pride in belonging to Aotearoa’s colourful and diverse rainbow community. This Pride Month, we want to ensure we are as festive as we are...
The South African Health Products Regulatory Authority has approved the use of a new form of injectable PrEP, giving a two-month HIV prevention option.
The South African Health Products Regulatory Authority (SAHPRA) announced the approval of the new form of PrEP on Friday, the 2nd of December, after World Aids...
The new funding could see an extra 5,500 New Zealanders being able to access the drugs.
Pharmac will expand the availability of pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for preventing HIV.
A boost of $191 million to Pharmac’s budget from the Government has allowed Pharmac to expand the eligibility...
Aucklanders are finding it difficult to access the safe sex drug following Lockdown, and Pharmac are slow to make the necessary adjustments to help.
Auckland’s ongoing COVID-19 restrictions have highlighted flaws in eligibility for Pre-exposure Prophylaxis (PreP).
PreP reduces the risk of HIV infection by 99 per cent. The drug is...
The iPrEP clinic is a New Zealand first and is modelled on a program in New York.
Body Positive is now offering “immediate access” to PrEP for those who need it quickly. In a New Zealand first, the peer support organisation has started an iPrEP clinic that works in conjunction...
Auckland DHB tells express that “the screening, prevention and treatment of HIV is a priority” refuting claims that some men have been turned away from accessing PrEP at their clinics.
The Auckland District Health Board have denied accusations that recent policy changes have left gay and bisexual men in Auckland...
A global three-year study has successfully shown that a long-acting injectable drug dosed every two months can be more effective than the daily PrEP.
Worldwide HIV medical specialist company ViiV Healthcare today announced an interim analysis of the HIV Prevention Trials Network that has been evaluating the safety and efficacy...
The company that manufactures the HIV prevention drug PrEP is preparing to test the pill against COVID-19 in an effort to find out if it could kill the virus or slow its spread.
Gilead Sciences, the manufacturer of Truvada, is set to test components of PrEP against COVID-19 but doesn’t expect...
